Parker WB - Search Results

1

The metabolism of 2-methyladenosine in Mycobacterium smegmatis.

Chen CK, Barrow EW, Allan PW, Bansal N, Maddry JA, Suling WJ, Barrow WW, Parker WB. Chen CK, et al. Among authors: parker wb. Microbiology (Reading). 2002 Jan;148(Pt 1):289-295. doi: 10.1099/00221287-148-1-289. Microbiology (Reading). 2002. PMID: 11782521 Free article.

2

Metabolism of 2-methyladenosine in Mycobacterium tuberculosis.

Parker WB, Barrow EW, Allan PW, Shaddix SC, Long MC, Barrow WW, Bansal N, Maddry JA. Parker WB, et al. Tuberculosis (Edinb). 2004;84(5):327-36. doi: 10.1016/j.tube.2004.02.004. Tuberculosis (Edinb). 2004. PMID: 15207808

3

Antimycobacterial activity of 2-methyl-adenosine.

Barrow EW, Westbrook L, Bansal N, Suling WJ, Maddry JA, Parker WB, Barrow WW. Barrow EW, et al. Among authors: parker wb. J Antimicrob Chemother. 2003 Nov;52(5):801-8. doi: 10.1093/jac/dkg444. Epub 2003 Oct 16. J Antimicrob Chemother. 2003. PMID: 14563890

4

Evaluation of 3-deaza-adenosine analogues as ligands for adenosine kinase and inhibitors of Mycobacterium tuberculosis growth.

Long MC, Allan PW, Luo MZ, Liu MC, Sartorelli AC, Parker WB. Long MC, et al. Among authors: parker wb. J Antimicrob Chemother. 2007 Jan;59(1):118-21. doi: 10.1093/jac/dkl448. Epub 2006 Nov 3. J Antimicrob Chemother. 2007. PMID: 17085766

5

Structure-activity relationship for adenosine kinase from Mycobacterium tuberculosis II. Modifications to the ribofuranosyl moiety.

Long MC, Shaddix SC, Moukha-Chafiq O, Maddry JA, Nagy L, Parker WB. Long MC, et al. Among authors: parker wb. Biochem Pharmacol. 2008 Apr 15;75(8):1588-600. doi: 10.1016/j.bcp.2008.01.007. Epub 2008 Feb 2. Biochem Pharmacol. 2008. PMID: 18329005 Free PMC article.

6

Effect of 9-benzyl-9-deazaguanine, a potent inhibitor of purine nucleoside phosphorylase, on the cytotoxicity and metabolism of 6-thio-2'-deoxyguanosine.

Parker WB, Allan PW, Niwas S, Montgomery JA, Bennett LL Jr. Parker WB, et al. Cancer Res. 1994 Apr 1;54(7):1742-5. Cancer Res. 1994. PMID: 8137289

7

Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase.

Parker WB, Allan PW, Hassan AE, Secrist JA 3rd, Sorscher EJ, Waud WR. Parker WB, et al. Cancer Gene Ther. 2003 Jan;10(1):23-9. doi: 10.1038/sj.cgt.7700520. Cancer Gene Ther. 2003. PMID: 12489025

8

Regioselective metalation of 6-methylpurines: synthesis of fluoromethyl purines and related nucleosides for suicide gene therapy of cancer.

Hassan AE, Parker WB, Allan PW, Secrist JA 3rd. Hassan AE, et al. Among authors: parker wb. Nucleosides Nucleotides Nucleic Acids. 2009 May;28(5):642-56. doi: 10.1080/15257770903091938. Nucleosides Nucleotides Nucleic Acids. 2009. PMID: 20183607

9

Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4'-thio-2'-deoxycytidine and 5-aza-4'-thio-2'-deoxycytidine.

Thottassery JV, Sambandam V, Allan PW, Maddry JA, Maxuitenko YY, Tiwari K, Hollingshead M, Parker WB. Thottassery JV, et al. Among authors: parker wb. Cancer Chemother Pharmacol. 2014 Aug;74(2):291-302. doi: 10.1007/s00280-014-2503-z. Epub 2014 Jun 8. Cancer Chemother Pharmacol. 2014. PMID: 24908436 Free PMC article.

10

Metabolism in human cells of the D and L enantiomers of the carbocyclic analog of 2'-deoxyguanosine: substrate activity with deoxycytidine kinase, mitochondrial deoxyguanosine kinase, and 5'-nucleotidase.

Bennett LL Jr, Allan PW, Arnett G, Shealy YF, Shewach DS, Mason WS, Fourel I, Parker WB. Bennett LL Jr, et al. Among authors: parker wb. Antimicrob Agents Chemother. 1998 May;42(5):1045-51. doi: 10.1128/AAC.42.5.1045. Antimicrob Agents Chemother. 1998. PMID: 9593124 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page